This article explains why Latin Americas demographic diversity, cost profile, and accelerating digital health infrastructure ...

Millions of people are alive today because of leukemia therapies that arose from UC research, including retired Army Major ...

Clinical trial failure insurance is turning biotech’s most costly risk into a manageable asset, opening new pathways for funding and innovation.

Melinda Bachini, a 15-year cholangiocarcinoma survivor, highlights the life-saving potential of clinical trials and advocates for increased access and participation. In April 2012, I walked into the ...

FDA should judge drugs on what they do in real life, not just in companies’ clinical trials by Aaron Kheriaty, opinion contributor - 07/08/25 7:00 AM ET AP Photo/Elise Amendola, file ...